Weight-loss drugs such as Ozempic or Wegovy and Zepbound are being hailed as game-changers in obesity treatment. However, these medications only work to a point; patients quickly lose weight initially, but this slows down and eventually comes to a halt. The pharmaceutical industry looks set to explore further advances in gut hormone-related drugs for weight loss. The aim is to gradually decrease the ‘plateau’ point to achieve greater weight loss. Drugs that stimulate multiple gut hormones could be the key, alongside increased dosages.
The ALPHV BlackCat and LockBit ransomware groups are causing havoc in the US healthcare sector, with a surge in cyberattacks on hospitals and pharmacies. The